Glucagon-Like Peptide-1 Receptor Agonists [agonisté receptoru pro glukagonu podobný peptid 1]
- Terms
-
agonisté receptoru pro GLP-1
analoga GLP-1
inkretinová mimetika
-
GLP-1 Agonists
GLP-1 Analogs
GLP-1 Receptor Agonists
GLP-1R Agonists
GLP1 Agonists
GLP1R Agonists
Incretin Mimetics
Compounds that stimulate the activity of GLUCAGON-LIKE PEPTIDE-1 RECEPTOR. Glucagon-like peptide-1 receptor agonists are used to treat TYPE 2 DIABETES and OBESITY.
- DUI
- D000097789 MeSH Browser
- CUI
- M000764445
- Previous indexing
- Glucagon-Like Peptide-1 Receptor (1993-2023)
- History note
- 2024
- Public note
- 2024
Allowable subheadings
- AD
- administration & dosage 11
- AE
- adverse effects 4
- AN
- analysis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification 1
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics
- PD
- pharmacology 20
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 25
- TO
- toxicity
- UR
- urine